Center for Medicine in the Public Interest (CMPI)
Peter Pitts is President of the Center for Medicine in the Public Interest and Chief Regulatory Officer for Adherent Health. A former member of the United States Senior Executive Service (SES), Peter was FDA’s Associate Commissioner for External Relations, serving as senior communications and policy adviser to the Commissioner. He supervised FDA’s Office of Public Affairs, Office of the Ombudsman, Office of Special Health Issues, Office of Executive Secretariat, and Advisory Committee Oversight and Management.
In 2010, he was named by Modern Healthcare magazine as one of the 300 “most powerful people in American healthcare.” He is a Visiting Lecturer at the École Supérieure des Sciences Économiques et Commerciales (Paris and Singapore), and has served as an adjunct professor at Indiana University’s School of Public and Environmental Affairs and Butler University.
Peter is a widely published author and commentator on matters of FDA policy and process, healthcare technology assessment and reimbursement issues, real-world evidence, off label-communications, pharmacovigilance, patient-focused drug development, GMP standards, drug safety, personalized medicine, clinical trial transparency, and drug importation. He serves on the boards of several policy institutes and foundations.